Publications by authors named "Birol Guvenc"

Claim this Profile
C
Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial.
Miguel R Abboud, Rodolfo D Cançado, Mariane De Montalembert, Wally R Smith, Hala Rimawi

Lancet Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentral Retrospective Analysis of Venetoclax-Based Treatments in AML and MDS: A Real-World Study by the Turkish Hematology Network Group.
Ibrahim Halil Acar, Muzeyyen Aslaner Ak, Gulsah Akyol, Taha Ulutan Kars, Yildiz Ipek, Birol Guvenc

Medicina (Kaunas)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options.
Bülent Zülfikar, Başak Koç, Fahri Şahin, Hatice İlgen Şaşmaz, Kaan Kavaklı

Res Pract Thromb Haemost· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic plasma exchange in critically ill children: 18-year experience of a tertiary care paediatric intensive care unit.
Faruk Ekinci, Dincer Yildizdas, Ozden Ozgur Horoz, Ahmet Yontem, Ibrahim Halil Acar, Birol Guvenc

Aust Crit Care· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience.
İbrahim Halil Açar, Birol Güvenç

Hematol Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data.
Müzeyyen Aslaner Ak, Ayfer Gedük, İbrahim Halil Acar, Merve Gökçen Polat, Cenk Sunu

Turk J Haematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey.
Tezer Kutluk, Berksoy Sahin, Meral Kirazli, Fahad Ahmed, Sinem Aydin

JAMA Netw Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study.
Mutlu Arat, Inci Alacacioglu, Ali Zahit Bolaman, Yahya Buyukasik, Seckin Cagirgan

Future Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Gemtuzumab Ozogamicin as Salvage Therapy in Patients with Acute Myeloid Leukemia: A Monocentric Real-World Experience.
İbrahim Halil Açar, Birol Guvenc

Medicina (Kaunas)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study.
Ibrahim Halil Acar, Sebnem Izmir Guner, Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk, Birol Guvenc

Mediterr J Hematol Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international study.
Tomoki Ito, David Sanford, Ciprian Tomuleasa, Hui-Hua Hsiao, Leonardo José Enciso Olivera, Birol Guvenc

Eur J Haematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy.
Toshihiro Miyamoto, David Sanford, Ciprian Tomuleasa, Hui-Hua Hsiao, Leonardo José Enciso Olivera, Birol Guvenc

Leuk Lymphoma· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.
Muzeyyen Aslaner Ak, Birsen Sahip, Ayfer Geduk, Mehmer Ali Ucar, Hacer Kale, Birol Guvenc

Indian J Hematol Blood Transfus· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Guray Saydam, Ridvan Ali, Ahmet Muzaffer Demir, Ahmet Emre Eskazan, Birol Guvenc

Int J Hematol Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.
Nur Soyer, Rıdvan Ali, Mehmet Turgut, İbrahim Celalettin Haznedaroğlu, Fergün Yılmaz

Turk J Med Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis.
Fatma Keklik Karadag, Mustafa Nuri Yenerel, Mehmet Yılmaz, Hava Uskudar, Vildan Ozkocaman, Birol Guvenc

Am J Blood Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia.
Zehra N Ozdemir, Osman Ilhan, Gulsum Ozet, Mesude Falay, Mustafa Yenerel, Birol Guvenc

Clin Lab· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patients.
Osman Ilhan, Zehra Narli Ozdemir, Gulsum Ozet, Mesude Falay, Mustafa Yenerel, Birol Guvenc

Transfus Apher Sci· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up.
Guray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, Akif S Yavuz, Ridvan Ali, Birol Guvenc

Hematology· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
Guray Saydam, Ibrahim C Haznedaroglu, Leylagul Kaynar, Akif S Yavuz, Ridvan Ali, Birol Guvenc

Hematology· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
Guray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, Akif S Yavuz, Ridvan Ali, Birol Guvenc

Expert Opin Pharmacother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B, Hepatitis C, Human immunodeficiency virus and syphilis frequency among blood donors: A single center study.
Sule Menziletoglu Yildiz, Aslihan Candevir, Filiz Kibar, Gulser Karaboga, Ferda Tekin Turhan, Birol Guvenc

Transfus Apher Sci· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Globin chain abnormalities with coexisting α-thalassemia mutations.
Birol Guvenc, Abdullah Canataroglu, Cagatay Unsal, Sule Menziletoglu Yildiz, Ferda Tekin Turhan

Arch Med Sci· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Thalassemia mutations and hemoglobinopathies in Adana, Turkey: results from a single center study.
Birol Guvenc, Abdullah Canataroglu, Cagatay Unsal, Sule Menziletoglu Yildiz, Ferda Tekin Turhan

Arch Med Sci· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): a case report and review of the literature.
Berna Bozkurt Duman, Berksoy Sahin, Melek Ergin, Birol Guvenc

Med Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis